BC Platforms Announces Partnerships with Three Finnish Biobanks to Advance Novel Diagnostics and Treatments
13 May 2022 – Zurich, Switzerland – BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has secured a multi-year contract, following a competitive procurement, to work with three Finnish Hospital District owned Biobanks (Clinical Biobanks) on improving access to, and automated management of, phenotypic, genomic, and clinical data. The project underpins Finland’s ambition to be a leading country for Real-World Data (RWD) studies, supporting the global development of novel treatments and enhancing the resilience of healthcare systems. Therapeutic areas of focus will include cancer, and neurodegenerative diseases.